Enterprise Value
66.05M
Cash
5.159M
Avg Qtr Burn
-5.679M
Short % of Float
12.07%
Insider Ownership
3.61%
Institutional Own.
11.94%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Multikine (Leukocyte Interleukin) Details Head and neck cancer, Cancer, Human papillomavirus, Solid tumor/s | BLA FDA meeting |